These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23366417)
1. Roles of bioactive sphingolipid metabolites in ovarian cancer cell biomechanics. Babahosseini H; Roberts PC; Schmelz EM; Agah M Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():2436-9. PubMed ID: 23366417 [TBL] [Abstract][Full Text] [Related]
3. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity. Tabuchi K; Hara A Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830 [TBL] [Abstract][Full Text] [Related]
4. An update on sphingosine-1-phosphate and other sphingolipid mediators. Fyrst H; Saba JD Nat Chem Biol; 2010 Jul; 6(7):489-97. PubMed ID: 20559316 [TBL] [Abstract][Full Text] [Related]
5. Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases. Drexler Y; Molina J; Mitrofanova A; Fornoni A; Merscher S J Am Soc Nephrol; 2021 Jan; 32(1):9-31. PubMed ID: 33376112 [TBL] [Abstract][Full Text] [Related]
6. Sphingolipid metabolites in inflammatory disease. Maceyka M; Spiegel S Nature; 2014 Jun; 510(7503):58-67. PubMed ID: 24899305 [TBL] [Abstract][Full Text] [Related]
7. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Tani M; Ito M; Igarashi Y Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225 [TBL] [Abstract][Full Text] [Related]
8. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Kihara A; Mitsutake S; Mizutani Y; Igarashi Y Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104 [TBL] [Abstract][Full Text] [Related]
9. Sphingolipid metabolites modulate dielectric characteristics of cells in a mouse ovarian cancer progression model. Salmanzadeh A; Elvington ES; Roberts PC; Schmelz EM; Davalos RV Integr Biol (Camb); 2013 Jun; 5(6):843-52. PubMed ID: 23609351 [TBL] [Abstract][Full Text] [Related]
10. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting. Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564 [TBL] [Abstract][Full Text] [Related]
11. High levels of sphingolipids in human breast cancer. Nagahashi M; Tsuchida J; Moro K; Hasegawa M; Tatsuda K; Woelfel IA; Takabe K; Wakai T J Surg Res; 2016 Aug; 204(2):435-444. PubMed ID: 27565080 [TBL] [Abstract][Full Text] [Related]
12. The role of sphingolipids in endothelial barrier function. Jernigan PL; Makley AT; Hoehn RS; Edwards MJ; Pritts TA Biol Chem; 2015 Jun; 396(6-7):681-91. PubMed ID: 25867999 [TBL] [Abstract][Full Text] [Related]
13. [Recent advances in study of sphingolipids on liver diseases]. Wang SY; Zhang JL; Zhang D; Bao XQ; Sun H Yao Xue Xue Bao; 2015 Dec; 50(12):1551-8. PubMed ID: 27169276 [TBL] [Abstract][Full Text] [Related]
14. Sphingolipid signaling pathways as potential therapeutic targets in gliomas. Van Brocklyn JR Mini Rev Med Chem; 2007 Oct; 7(10):984-90. PubMed ID: 17979800 [TBL] [Abstract][Full Text] [Related]
16. The influences of sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea. Nishimura B; Tabuchi K; Nakamagoe M; Hara A Neurosci Lett; 2010 Nov; 485(1):1-5. PubMed ID: 20709153 [TBL] [Abstract][Full Text] [Related]